Hamzehpour, H.; Óskarsdóttir, Á.; Jónsson, H.; Jónsdóttir, F.; Sigurjónsson, Ó.E.; Snorradottir, B.S.
Transdermal Drug Delivery of Tazarotene: Determining Tazarotene’s Potential in Local Transdermal Therapy. Pharmaceutics 2024, 16, 64.
https://doi.org/10.3390/pharmaceutics16010064
AMA Style
Hamzehpour H, Óskarsdóttir Á, Jónsson H, Jónsdóttir F, Sigurjónsson ÓE, Snorradottir BS.
Transdermal Drug Delivery of Tazarotene: Determining Tazarotene’s Potential in Local Transdermal Therapy. Pharmaceutics. 2024; 16(1):64.
https://doi.org/10.3390/pharmaceutics16010064
Chicago/Turabian Style
Hamzehpour, Helena, Ástrós Óskarsdóttir, Helgi Jónsson, Fjóla Jónsdóttir, Ólafur E. Sigurjónsson, and Bergthora S. Snorradottir.
2024. "Transdermal Drug Delivery of Tazarotene: Determining Tazarotene’s Potential in Local Transdermal Therapy" Pharmaceutics 16, no. 1: 64.
https://doi.org/10.3390/pharmaceutics16010064
APA Style
Hamzehpour, H., Óskarsdóttir, Á., Jónsson, H., Jónsdóttir, F., Sigurjónsson, Ó. E., & Snorradottir, B. S.
(2024). Transdermal Drug Delivery of Tazarotene: Determining Tazarotene’s Potential in Local Transdermal Therapy. Pharmaceutics, 16(1), 64.
https://doi.org/10.3390/pharmaceutics16010064
